Are you over 18 and want to see adult content?
More Annotations
![A complete backup of https://spotsocials.com](https://www.archivebay.com/archive6/images/67219b37-c6e9-429b-8790-c24ac7513f40.png)
A complete backup of https://spotsocials.com
Are you over 18 and want to see adult content?
![A complete backup of https://seitenbacher.de](https://www.archivebay.com/archive6/images/38c71ae7-674f-4c2d-8186-94a06715ce7c.png)
A complete backup of https://seitenbacher.de
Are you over 18 and want to see adult content?
![A complete backup of https://lazienkaplus.pl](https://www.archivebay.com/archive6/images/4ec61f90-96e5-4a37-b147-f31959e19530.png)
A complete backup of https://lazienkaplus.pl
Are you over 18 and want to see adult content?
![A complete backup of https://azbyka.ru](https://www.archivebay.com/archive6/images/200937c3-e8d1-46dd-b28b-18cfa87cb4f2.png)
A complete backup of https://azbyka.ru
Are you over 18 and want to see adult content?
![A complete backup of https://bocopa.com](https://www.archivebay.com/archive6/images/ba50e17b-6fdc-4719-a6f3-41149bf19e9f.png)
A complete backup of https://bocopa.com
Are you over 18 and want to see adult content?
![A complete backup of https://renovatedfaith.com](https://www.archivebay.com/archive6/images/a9b969a7-8d5b-4102-9d55-d17d48154046.png)
A complete backup of https://renovatedfaith.com
Are you over 18 and want to see adult content?
![A complete backup of https://sugarloafmd.com](https://www.archivebay.com/archive6/images/8829bf7c-213d-41ac-a749-396f73ca9054.png)
A complete backup of https://sugarloafmd.com
Are you over 18 and want to see adult content?
![A complete backup of https://ugmonk.com](https://www.archivebay.com/archive6/images/d97a85af-9df4-4968-8cb8-2edfb9af9285.png)
A complete backup of https://ugmonk.com
Are you over 18 and want to see adult content?
![A complete backup of https://oray.com](https://www.archivebay.com/archive6/images/6838ff13-6b6b-4dd0-812e-5aeafab21de0.png)
A complete backup of https://oray.com
Are you over 18 and want to see adult content?
![A complete backup of https://russbrown.com](https://www.archivebay.com/archive6/images/22580cd7-99dd-4822-a95e-6cae05e01a1e.png)
A complete backup of https://russbrown.com
Are you over 18 and want to see adult content?
![A complete backup of https://bestwellcare.com](https://www.archivebay.com/archive6/images/d33e0b25-2aa1-46a0-9571-7dcf2052cf2d.png)
A complete backup of https://bestwellcare.com
Are you over 18 and want to see adult content?
![A complete backup of https://adw-kupon.ru](https://www.archivebay.com/archive6/images/945f3455-26ee-4d10-bdeb-49842a9523a1.png)
A complete backup of https://adw-kupon.ru
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of https://lightpaintingphotography.com](https://www.archivebay.com/archive6/images/bf7875ec-8f19-4e32-81f9-4a6b894990d5.png)
A complete backup of https://lightpaintingphotography.com
Are you over 18 and want to see adult content?
![A complete backup of https://wpteam.org](https://www.archivebay.com/archive6/images/fe37c358-621e-42d0-b8f2-d190e5a25d66.png)
A complete backup of https://wpteam.org
Are you over 18 and want to see adult content?
![A complete backup of https://realfoodwholehealth.com](https://www.archivebay.com/archive6/images/98272645-7375-4e30-85b4-6fd3367b9096.png)
A complete backup of https://realfoodwholehealth.com
Are you over 18 and want to see adult content?
![A complete backup of https://antabuse911.com](https://www.archivebay.com/archive6/images/33ec3397-403c-45d1-8b98-70d0b446d8b2.png)
A complete backup of https://antabuse911.com
Are you over 18 and want to see adult content?
![A complete backup of https://kidgredients.com.au](https://www.archivebay.com/archive6/images/f5065801-6bdc-4eb6-9f3a-0399e21e8ca9.png)
A complete backup of https://kidgredients.com.au
Are you over 18 and want to see adult content?
![A complete backup of https://viamengo.com](https://www.archivebay.com/archive6/images/116a166b-3ffd-41de-8486-b877a29ba1da.png)
A complete backup of https://viamengo.com
Are you over 18 and want to see adult content?
![A complete backup of https://realstreetperformance.com](https://www.archivebay.com/archive6/images/7fb50186-0064-4a1c-984d-7f028ba7f56f.png)
A complete backup of https://realstreetperformance.com
Are you over 18 and want to see adult content?
![A complete backup of https://autoinsurancequotesjazz.com](https://www.archivebay.com/archive6/images/b6dd13de-5f64-4b27-bb10-40129f83a10e.png)
A complete backup of https://autoinsurancequotesjazz.com
Are you over 18 and want to see adult content?
![A complete backup of https://unexpectedproductions.org](https://www.archivebay.com/archive6/images/f0b0643f-84cd-45f6-ac34-cef9909a3481.png)
A complete backup of https://unexpectedproductions.org
Are you over 18 and want to see adult content?
![A complete backup of https://heinemann.com](https://www.archivebay.com/archive6/images/a6899d7b-918c-4e43-98f3-f2c8e05baa3b.png)
A complete backup of https://heinemann.com
Are you over 18 and want to see adult content?
![A complete backup of https://wins-casinos.com](https://www.archivebay.com/archive6/images/52b20591-3949-473b-a895-6531eb115807.png)
A complete backup of https://wins-casinos.com
Are you over 18 and want to see adult content?
![A complete backup of https://ibanfirst.com](https://www.archivebay.com/archive6/images/a18b8ac7-56a4-48ee-a7fd-cda58e22a8fb.png)
A complete backup of https://ibanfirst.com
Are you over 18 and want to see adult content?
Text
VIDEOSCONTACT
April 15, 2021. OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse™" for the Treatment of Solid Tumors. April 14, 2021. OncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1 Checkpoint TAVO – ONCOSEC MEDICAL INCORPORATED Roll over images to reveal how TAVO is designed to work. Step 1. Cancer is identified in the body. Step 2. DNA-based interleukin-12 (IL-12), a naturally occurring protein, is injected directly into the tumor. Step 3. The applicator supplies a sequence of short-duration electrical pulses through a series of needles. Step 4.MANAGEMENT TEAM
Mr. O’Connor is the Chief Executive Officer, President and Director of OncoSec Medical Incorporated, a NJ based biotech company developing TAVO, an intratumoral cancer immunotherapy that utilizes IL-12. While CEO, Mr. O’Connor has launched two KEYNOTE studies combining Merck’s Keytruda®* in PD-1 checkpoint refractory metastaticmelanoma
PIPELINE – ONCOSEC MEDICAL INCORPORATED New Jersey Headquarters 24 N. Main St Pennington, NJ 08534. R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121OPEN POSITIONS
OPEN POSITIONS. Please find below a list of open positions at OncoSec. To apply, email your resume and cover letter to careers@oncosec.com . In the subject line of your email, please enter the exact name of the position for which you’re applying. Sr. In Vivo Specialist. Supports the In Vivo team on preclinical projects by providing ONCOSEC'S NOVEL COVID-19 VACCINE CANDIDATE FEATURED IN PENNINGTON, N.J. and SAN DIEGO, July 13, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA–based cancer immunotherapies, today announced the promising potential of its novel DNA–encodable vaccine candidate, CORVax12, which is designed to act as a prophylactic vaccine to ONCOSEC ANNOUNCES POSITIVE INTERIM DATA FROM KEYNOTE-695 PENNINGTON, N.J. and SAN DIEGO, Nov. 9, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced new positive interim data from its KEYNOTE-695 registration-enabled Phase 2b clinical trial evaluating TAVO™ (tavokinogene telseplasmid), a DNA plasmid-based interleukin-12 (IL-12), in combination with KEYTRUDA® ONCOSEC TO PRESENT ENCORE INTERIM DATA FROM THE KEYNOTE PENNINGTON, N.J. and SAN DIEGO, April 15, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnology company focused on cytokine-based intratumoral immunotherapies, today announced that it will be presenting encore interim data from its KEYNOTE-695 registration-enabled Phase 2b clinical trial evaluating TAVO™ ANNUAL REPORTS :: ONCOSEC MEDICAL INCORPORATED (ONCS) New Jersey Headquarters 24 N. Main St Pennington, NJ 08534 R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121 EVENTS & PRESENTATIONS :: ONCOSEC MEDICAL INCORPORATED (ONCS) New Jersey Headquarters 24 N. Main St Pennington, NJ 08534 R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121 ONCOSEC MEDICAL INCORPORATEDPIPELINEPARTNERINGPATIENTSINVESTORSMEDIA &VIDEOSCONTACT
April 15, 2021. OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse™" for the Treatment of Solid Tumors. April 14, 2021. OncoSec Medical Sponsoring KOL Webinar On A High Unmet Medical Need: Anti-PD-1 Checkpoint TAVO – ONCOSEC MEDICAL INCORPORATED Roll over images to reveal how TAVO is designed to work. Step 1. Cancer is identified in the body. Step 2. DNA-based interleukin-12 (IL-12), a naturally occurring protein, is injected directly into the tumor. Step 3. The applicator supplies a sequence of short-duration electrical pulses through a series of needles. Step 4.MANAGEMENT TEAM
Mr. O’Connor is the Chief Executive Officer, President and Director of OncoSec Medical Incorporated, a NJ based biotech company developing TAVO, an intratumoral cancer immunotherapy that utilizes IL-12. While CEO, Mr. O’Connor has launched two KEYNOTE studies combining Merck’s Keytruda®* in PD-1 checkpoint refractory metastaticmelanoma
PIPELINE – ONCOSEC MEDICAL INCORPORATED New Jersey Headquarters 24 N. Main St Pennington, NJ 08534. R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121OPEN POSITIONS
OPEN POSITIONS. Please find below a list of open positions at OncoSec. To apply, email your resume and cover letter to careers@oncosec.com . In the subject line of your email, please enter the exact name of the position for which you’re applying. Sr. In Vivo Specialist. Supports the In Vivo team on preclinical projects by providing ONCOSEC'S NOVEL COVID-19 VACCINE CANDIDATE FEATURED IN PENNINGTON, N.J. and SAN DIEGO, July 13, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA–based cancer immunotherapies, today announced the promising potential of its novel DNA–encodable vaccine candidate, CORVax12, which is designed to act as a prophylactic vaccine to ONCOSEC ANNOUNCES POSITIVE INTERIM DATA FROM KEYNOTE-695 PENNINGTON, N.J. and SAN DIEGO, Nov. 9, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") today announced new positive interim data from its KEYNOTE-695 registration-enabled Phase 2b clinical trial evaluating TAVO™ (tavokinogene telseplasmid), a DNA plasmid-based interleukin-12 (IL-12), in combination with KEYTRUDA® ONCOSEC TO PRESENT ENCORE INTERIM DATA FROM THE KEYNOTE PENNINGTON, N.J. and SAN DIEGO, April 15, 2021 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnology company focused on cytokine-based intratumoral immunotherapies, today announced that it will be presenting encore interim data from its KEYNOTE-695 registration-enabled Phase 2b clinical trial evaluating TAVO™ ANNUAL REPORTS :: ONCOSEC MEDICAL INCORPORATED (ONCS) New Jersey Headquarters 24 N. Main St Pennington, NJ 08534 R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121 EVENTS & PRESENTATIONS :: ONCOSEC MEDICAL INCORPORATED (ONCS) New Jersey Headquarters 24 N. Main St Pennington, NJ 08534 R&D Laboratories 3565 General Atomics Court #100 San Diego, CA 92121 PATIENTS – ONCOSEC MEDICAL INCORPORATED OncoSec exists for you, the patient. At OncoSec Medical, we are currently focused on two tumor indications– checkpoint-refractory, late stage metastatic melanoma and metastatic triple negative breast cancer (mTNBC). Melanoma is a cancer of the skin. Most melanomas originate on sun-exposed skin, though they can also develop in other parts of the body, including the eyes and sun-shielded TECHNOLOGY – ONCOSEC MEDICAL INCORPORATED The Unmet Need. Every year, there are over 18 million cases of cancer detected and 10 million cancer related deaths. In fact, it is estimated that there are 1.6 million new cases of solid tumors in the U.S. alone – presenting one of the largest challenges to oncologists. Certain cancers can bypass or hide from the immune systemby engaging an
CORVAX12 – ONCOSEC MEDICAL INCORPORATED CORVax12 is the only DNA vaccine that uses an immune stimulant to promote an immune response against the SARS-CoV-2 virus. The CORVax vaccine approach combines the co-administration of TAVO™ (plasmid IL-12) with a DNA-encodable version of the SARS-CoV-2 spike or “S” glycoprotein to enhance immunogenicity of the component developed by MEDIA – ONCOSEC MEDICAL INCORPORATED OncoSec Medical @OncoSec ·. 19 May. In recognition of #Melanoma and #SkinCancerAwarenessMonth, we are proud to partner with melanoma advocacy groups as part of our #TogetherAgainstCancer campaign. Learn more about our partnership with the melanoma advocacy community here: https://bit.ly/32EMZCO.OPEN POSITIONS
OPEN POSITIONS. Please find below a list of open positions at OncoSec. To apply, email your resume and cover letter to careers@oncosec.com . In the subject line of your email, please enter the exact name of the position for which you’re applying. Sr. In Vivo Specialist. Supports the In Vivo team on preclinical projects by providing INVESTOR RELATIONS :: ONCOSEC MEDICAL INCORPORATED (ONCS) Company Overview. OncoSec Medical Incorporated is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead immunotherapy investigational product candidate – TAVO™ (tavokinogene telseplasmid) – enables the intratumoral delivery of DNA-based ONCOSEC'S NOVEL COVID-19 VACCINE CANDIDATE FEATURED IN PENNINGTON, N.J. and SAN DIEGO, July 13, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late-stage intratumoral DNA–based cancer immunotherapies, today announced the promising potential of its novel DNA–encodable vaccine candidate, CORVax12, which is designed to act as a prophylactic vaccine to VISCERAL LESION APPLICATOR Visceral Lesion Applicator (VLA) OncoSec’s investigational visceral lesion applicator (VLA) technology is designed to treat non-cutaneous, internal tumors through direct delivery of our lead product candidate, TAVO™, or other immunologically relevant genes, including our SPARKplasmid.
PARTNERING – ONCOSEC MEDICAL INCORPORATED OncoSec has access to top-notch commercial talent and resources through its strategic partnership with Sirtex Medical US Holdings, Inc. (Sirtex). Sirtex will support and assist OncoSec with pre-marketing activities for its lead product candidate, TAVO™, and its visceral lesion applicator (VLA) in exchange for low single-digitroyalties on
ONCOSEC ANNOUNCES APPOINTMENT OF SANDRA AUNG, PH.D. AS PENNINGTON, N.J. and SAN DIEGO, Oct. 12, 2020 /PRNewswire/ -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a company developing late- stage intra-tumoral cancer immunotherapies, today announced that Sandra Aung, Ph.D. joined the Company as Senior Vice President, Chief Clinical Development Officer.Skip to content
* Keynote 695 Clinical Trial* About
* About
* Join The Team
* Management Team
* Pipeline
* Technology
* Technology
* Tavo
* VLA
* Combination Approach* Publications
* Partnering
* Patients
* Patients
* Resources
* Expanded Access
* Investors
* Media
* Contact
Menu Toggle
* About__Menu Toggle* About
* Join The Team
* Management Team
* Pipeline
* Technology__Menu Toggle* Technology
* Tavo
* VLA
* Combination Approach* Publications
* Partnering
* Patients__Menu Toggle* Patients
* Resources
* Expanded Access
* Investors
* Media
* Contact
ONCOSEC’S VLA: VISCERAL LESION APPLICATORLEARN MORE
TAVO™
INVESTIGATIONAL INTRATUMORAL CANCER IMMUNOTHERAPYLEARN MORE
ONCOSEC AWARDED “BEST TECHNOLOGY SCIENTIFIC ABSTRACT” BY THE SOCIETY OF INTERVENTIONAL ONCOLOGYLEARN MORE
TAVO™ MONOTHERAPY RESULTS IN METASTATIC MELANOMA HIGHLIGHTED IN _ANNALS OF ONCOLOGY_Read More
NEWS & EVENTS
ONCOSEC CORPORATE PRESENTATION CLINICAL CANCER RESEARCH * OncoSec Presents Pre-Clinical Data from Its Visceral Lesion Applicator (VLA) and APOLLO Feasibility Study Demonstrating TAVO™ Can Be Safely Delivered and Electroporated in Liver at the Online Society of Interventional Radiology Annual MeetingApril 21, 2020
* OncoSec Appoints Renowned Oncologist and Immunologist, Herbert Kim Lyerly, M.D., Duke University, to its Board of DirectorsApril 20, 2020
FEATURED ARTICLES
ANNALS OF ONCOLOGY
Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.MARCH 16, 2020
CLINICAL CANCER RESEARCH Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel CellCarcinoma.
FEBRUARY 1, 2020
NATURE GENE THERAPY
Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.SEPTEMBER 30, 2019
DESIGNED TO ARM THE IMMUNE SYSTEM TO FIGHT CANCER We are investigating the potential for our lead product candidate, TAVO, through the intratumoral administration of IL-12, to stimulate systemic immune response and to become an innovative and potentially transformative therapy option for the treatment of cancer.CLINICAL PIPELINE
Our core technology platform continues to advance through clinical trials for various cancersLearn More
TECHNOLOGY
Our plasmid DNA delivery platform is designed to boost the body’s immune system to target and attack cancerLearn More
PARTNERSHIPS
We have a track record of establishing, operating and evolving high-performance partnerships globallyLearn More
IT'S ALL ABOUT YOU
Visit our Patient Portal NEW APPROACHES, NEW HOPE Learn More About Oncosec“TAVO” IL-12
Fighting tumors directly.FRAN’S STORY
Reclaiming Independence from Melanoma _“I was headed down a one-way street with dead end.”_Watch Video
Sign Up for our mailing list to stay current on all of our exciting new research and developments.Get Email Alerts
LINKS
* About
* Pipeline
* Technology
* Partnering
* Patients
* Media
* Investors
* Contact
* KEYNOTE 695 CLINICAL TRIALCONTACT
New Jersey Headquarters24 N. Main St
Pennington, NJ 08534R&D Laboratories
3565 General Atomics Court #100San Diego, CA 92121
p | 855.662.6732
f | 858.430.3832
Investors@OncoSec.com ONCOSEC’S INVESTIGATIONAL PRODUCTS HAVE NOT BEEN APPROVED OR CLEAREDBY THE FDA.
__ __
__
__
2020 OncoSec Medical Incorporated. All Rights Reserved. Q12-003052-01 REV E.Details
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0